EC Healthcare (HKG:2138) expects its net loss to widen to between HK$380 million and HK$420 million for the fiscal year ended March 31, compared with a loss of HK$167.2 million a year earlier.
The company attributed the forecast mainly to non-cash impairment charges on goodwill, intangible assets, receivables and other assets, along with fair value losses on certain investments, according to a Hong Kong bourse filing on Thursday. Revenue is also expected to fall to HK$3.70 billion from HK$4.14 billion in the prior year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments